FNDC5 and type 2 diabetes mellitus: It was also reported previously that circulating irisin concentration was negatively associated with obesity and insulin resistance and was lower in type 2 diabetes participants [26]; additionally, circulating irisin levels were significantly decreased in obese patients with insulin resistance compared to their controls [27].